Every October brings new ICD-10-CM changes for healthcare organizations. While the fiscal year (FY) 2027 update is smaller than many recent releases, it includes 190 new codes, 30 deletions, and four code title revisions.
For health systems, however, preparing for the update isn’t simply a matter of loading new codes. Changes in specificity and classification can affect clinical documentation, coding workflows, mappings, reporting, and the way conditions appear in longitudinal data.
In our recent webinar, Your guide to the ICD-10-CM 2027 updates, Theresa Rihanek, MHA, RHIA, CCS, Sr. Mapping Informaticist; June Bronnert, MHI, RHIA, CCS, CCS-P, SVP, Global Clinical Services; and Julie Glasgow, MD, Senior Staff Clinical Terminologist, reviewed the changes and what they could mean for coding, documentation, and data.
Pressed for time? Here are five key takeaways from their discussion.
1. Genetic conditions are getting more specific ICD-10-CM codes
FY 2027 adds dedicated codes for several genetic cancer predisposition syndromes, including:
- Lynch syndrome (QA1.71)
- Familial cancer syndrome with a pathogenic BRCA1 mutation (QA1.790)
- Familial cancer syndrome with a pathogenic BRCA2 mutation (QA1.791)
- Li-Fraumeni syndrome (QA1.792)
These codes make it easier to distinguish genetic conditions that carry different cancer risks, screening needs, and management pathways.
2. More specificity across oncology and cardiology
FY 2027 adds more specificity across several clinical areas, including:
- Oncology: New codes identify secondary malignant neoplasms of the larynx (C78.31), pharynx (C78.32), and oral cavity (C79.83).
- Cardiology: New codes distinguish familial genetic dilated cardiomyopathy (I42.01), arrhythmogenic cardiomyopathy (I42.81), Brugada syndrome (I49.81), and ventricular bigeminy (I49.82).
For coding and CDI teams, additional specificity in codes fully reflects the clinical detail captured in the record. Site, laterality, cause, disease subtype, and other distinguishing details can also help support more specific coding.
3. New codes recognize emerging and distinct conditions
The FY 2027 update includes several conditions that previously lacked their own classification, giving coding and clinical teams greater specificity. Key additions include:
- Post-bariatric hypoglycemia (E89.83): Distinguishes the condition from other forms of post-procedural hypoglycemia
- Pulmonary mycetoma (J40B): Identifies a fungal mass in the lungs
- VEXAS syndrome (M04.3): Recognizes this rare autoinflammatory disorder
- Intestinal failure-associated liver disease (K76.83): Identifies liver damage associated with long-term intestinal failure and parenteral nutrition
For health systems, dedicated codes make it easier to distinguish these conditions in coded data rather than grouping them under broader classifications.
4. Environmental and toxic exposures get more granular coding
FY 2027 expands coding for environmental, chemical, and military exposures. Key additions include:
- Medetomidine toxic effects (T65.85-): Captures effects from a veterinary sedative increasingly found in the illicit fentanyl supply
- Gadolinium: New codes capture abnormal blood levels (R78.72) and contact or exposure (Z77.013)
- Military exposures: New Z codes distinguish burn-pit exposure (Z77.32) and Agent Orange exposure (Z77.33)
- Blast overpressure: New codes distinguish low- and high-level exposure
For analytics teams, these changes may also require updates to historical reporting. For example, Agent Orange exposure was previously included under Z77.39 but now has its own code, Z77.33.
5. New codes can disrupt longitudinal reporting
New codes can change how conditions appear in longitudinal data. For example, plantar fasciitis and plantar fascial fibromatosis were previously classified together under M72.2. Beginning in FY 2027, they are classified separately, with plantar fasciitis moving to new codes under M67.
This means reports and patient cohorts that span the October 1 transition may need to account for both the old and new classifications. Health systems should review affected mappings, cohort definitions, dashboards, and reporting logic to help ensure the same clinical concepts remain identifiable across the transition.
Preparing for the FY 2027 ICD-10-CM update
The FY 2027 update may be smaller in volume, but the changes continue to push ICD-10-CM toward greater clinical specificity.
For health systems, preparation should extend beyond simply adding new codes and retiring deleted ones. Coding, CDI, informatics, and analytics teams should consider:
- Whether documentation workflows capture the specificity required by new codes
- Which terminology and mapping updates are needed across clinical systems
- Whether reports, cohorts, or quality measures rely on codes that have been reclassified
- How longitudinal analyses will account for conditions represented differently before and after October 1
- Whether downstream teams and systems are prepared for the updated classifications
Getting these pieces aligned before the transition can help preserve clinical meaning as data moves from documentation to coding, reporting, and analytics.
